```json
{
"content": [
{
"type": "paragraph",
"content": "The Core Needle Biopsy for Soft Tissue market is a critical segment within diagnostic oncology and orthopedic pathology, enabling minimally invasive tissue sampling for cancer and musculoskeletal disorder diagnosis. As a precision-driven procedure, it offers advantages over traditional surgical biopsies, including reduced recovery time and lower complication risks, making it integral to modern clinical workflows. The global Core Needle Biopsy for Soft Tissue market size reached $1.2 billion in 2023, reflecting robust adoption in oncology and orthopedic applications. With a CAGR of 5.8% projected from 2026 to 2033, the market is poised for sustained expansion, driven by rising cancer incidence, advancements in imaging-guided biopsy technologies, and growing demand for non-invasive diagnostics."
},
{
"type": "chart",
"chartType": "segment-stacked",
"data": {
"segments": ["Vacuum-assisted", "Manual", "Image-guided"],
"periods": ["2021", "2022", "2023", "2024", "2025", "2026", "2027", "2028", "2029", "2030", "2031", "2032", "2033"],
"values": [
[250, 270, 300, 320, 350, 380, 410, 440, 470, 500, 530, 560, 590], // Vacuum-assisted
[180, 190, 200, 210, 220, 230, 240, 250, 260, 270, 280, 290, 300], // Manual
[150, 160, 180, 200, 220, 250, 280, 310, 340, 370, 400, 430, 460] // Image-guided
]
}
},
{
"type": "paragraph",
"content": "The market is shaped by technological innovation, particularly the integration of AI-driven imaging systems to enhance biopsy accuracy, and regulatory tailwinds promoting standardized protocols for soft tissue diagnostics. North America remains the largest regional market, fueled by early adoption of advanced biopsy systems and high healthcare spending. Conversely, Asia-Pacific is the fastest-growing region, driven by expanding access to diagnostic infrastructure and rising awareness of minimally invasive procedures. Strategic partnerships between medical device firms and hospitals, alongside R&D investments in automation, will further accelerate industry expansion through 2033."
}
]
}
```
